norethindrone and Coronary Artery Disease

norethindrone has been researched along with Coronary Artery Disease in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Falkeborn, M; Lithell, H; Naessén, T; Persson, I; Vessby, B	1
Barton, M; Haas, E; Meyer, MR	1
Fernandes, CE; Ferreira, JA; Machado, RB; Melo, NR; Peixoto, S; Pompei, LM	1

Trials

2 trial(s) available for norethindrone and Coronary Artery Disease

Article	Year
Lipids and antioxidative effects of estradiol and sequential norethisterone acetate treatment in a 3-month randomized controlled trial. Climacteric : the journal of the International Menopause Society, 2002, Volume: 5, Issue:3 Topics: Administration, Oral; Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Apoprotein(a); Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Chromatography, High Pressure Liquid; Coronary Artery Disease; Double-Blind Method; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Fatty Acids; Female; Humans; Lipid Peroxidation; Lipoprotein(a); Malondialdehyde; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Tocopherols; Treatment Outcome; Triglycerides	2002
Effects of estradiol and norethisterone on lipids, insulin resistance and carotid flow. Maturitas, 2008, Mar-20, Volume: 59, Issue:3 Topics: Carotid Arteries; Coronary Artery Disease; Double-Blind Method; Drug Interactions; Estradiol; Estrogen Replacement Therapy; Female; Humans; Insulin Resistance; Lipids; Middle Aged; Norethindrone; Pulsatile Flow	2008

Article

Year

Lipids and antioxidative effects of estradiol and sequential norethisterone acetate treatment in a 3-month randomized controlled trial.

Climacteric : the journal of the International Menopause Society, 2002, Volume: 5, Issue:3

Topics: Administration, Oral; Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Apoprotein(a); Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Chromatography, High Pressure Liquid; Coronary Artery Disease; Double-Blind Method; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Fatty Acids; Female; Humans; Lipid Peroxidation; Lipoprotein(a); Malondialdehyde; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Tocopherols; Treatment Outcome; Triglycerides

2002

Effects of estradiol and norethisterone on lipids, insulin resistance and carotid flow.

Maturitas, 2008, Mar-20, Volume: 59, Issue:3

Topics: Carotid Arteries; Coronary Artery Disease; Double-Blind Method; Drug Interactions; Estradiol; Estrogen Replacement Therapy; Female; Humans; Insulin Resistance; Lipids; Middle Aged; Norethindrone; Pulsatile Flow

2008

Other Studies

1 other study(ies) available for norethindrone and Coronary Artery Disease

Article	Year
Hormone replacement therapy and atherosclerosis in postmenopausal women: does aging limit therapeutic benefits? Arteriosclerosis, thrombosis, and vascular biology, 2007, Volume: 27, Issue:8 Topics: Age Factors; Aged; Aging; Atherosclerosis; Coronary Artery Disease; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Incidence; Middle Aged; Norethindrone; Postmenopause; Prognosis; Risk Factors; Treatment Outcome	2007

Article

Year

Hormone replacement therapy and atherosclerosis in postmenopausal women: does aging limit therapeutic benefits?

Arteriosclerosis, thrombosis, and vascular biology, 2007, Volume: 27, Issue:8

Topics: Age Factors; Aged; Aging; Atherosclerosis; Coronary Artery Disease; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Incidence; Middle Aged; Norethindrone; Postmenopause; Prognosis; Risk Factors; Treatment Outcome

2007